After charting several related moves earlier this year, Boehringer Ingelheim is returning to the antibody-drug conjugate well ...
Boehringer Ingelheim, which has so far inked at least five hefty partnerships—including its latest one with South Korea’s ...
German family-owned pharma major Boehringer Ingelheim and AimedBio, a Korean biotech company pioneering antibody-drug ...
As pharmaphorum reported during ESMO 2025, fresh from a return to oncology with the FDA approval of zongertinib as a ...
According to Boehringer, Hernexeos achieved a 77% objective response rate (OOR) in a cohort of previously untreated HER2+ ...
Boehringer Ingelheim unveiled its evolved company brand this week, featuring the corporate claim: “Life forward.” The German pharma giant said the claim builds upon the company’s purpose of ...
Boehringer Ingelheim announced an agreement with Quallent Pharmaceuticals, a private label pharmaceutical distributor, to help expand patient access to citrate-free adalimumab-adbm, Boehringer’s ...
Data sharing technology company Datavant has expanded its collaboration with pharmaceutical company Boehringer Ingelheim to support Boehringer's real-world evidence initiatives. The extended ...
INGELHEIM, Germany & SAN DIEGO--(BUSINESS WIRE)--Boehringer Ingelheim today announced the signing of an option to acquire Trutino Biosciences Inc. (the “Transaction”), a San Diego-based biotech ...
INGELHEIM, Germany & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback